THE PHARMACOKINETICS AND IMMUNOGENICITY OF USTEKINUMAB AND ADALIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: RESULTS FROM THE SEAVUE STUDY

Silvio Danese  1     Tony Ma  2     Omoniyi J. Adedokun  3     Christopher Gasink  2     Kamal Patel  4     James Izanec  2     Stephen B Hanauer  5     Ellen J. Scherl  6    
1 Humanitas Clinical and Research Center, Humanitas University, Milan, Italy
2 Janssen Scientific Affairs, LLC, Horsham, United States
3 Janssen Research & Development, LLC, Spring House, United States
4 St. Georges University Hospitals, London, United Kingdom
5 Northwestern University Feinberg School of Medicine, Chicago, United States
6 New York Presbyterian Hospital Weill Cornell Medicine, New York, United States

Topic
IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing